PERK-IN-2
|
P651541-100mg
|
≥99% |
1337531-83-5 |
100mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-5mg
|
≥99% |
927691-21-2 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-50mg
|
≥99% |
927691-21-2 |
50mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-25mg
|
≥99% |
927691-21-2 |
25mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-1mg
|
≥99% |
927691-21-2 |
1mg
|
¥ 380.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-10mg
|
≥99% |
927691-21-2 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
PQ-10
|
P651532-100mg
|
≥99% |
927691-21-2 |
100mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
PCSK9-IN-12
|
P651528-5mg
|
≥99% |
2455427-91-3 |
5mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
PCSK9-IN-12
|
P651528-25mg
|
≥99% |
2455427-91-3 |
25mg
|
¥ 8900.9
|
期货,请咨询 |
阿拉丁 |
PCSK9-IN-12
|
P651528-10mg
|
≥99% |
2455427-91-3 |
10mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
PDCD4-IN-1
|
P651526-5mg
|
|
494763-64-3 |
5mg
|
¥ 600.9
|
期货,请咨询 |
阿拉丁 |
PDCD4-IN-1
|
P651526-50mg
|
|
494763-64-3 |
50mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
PDCD4-IN-1
|
P651526-25mg
|
|
494763-64-3 |
25mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
PDCD4-IN-1
|
P651526-10mg
|
|
494763-64-3 |
10mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
PDCD4-IN-1
|
P651526-100mg
|
|
494763-64-3 |
100mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
PI3K/mTOR Inhibitor-13 sodium
|
P651523-5mg
|
|
2361009-23-4 |
5mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
PI3K/mTOR Inhibitor-13 sodium
|
P651523-10mg
|
|
2361009-23-4 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
(+)-Penbutolol
|
P651513-5mg
|
≥95% |
38363-41-6 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
(+)-Penbutolol
|
P651513-50mg
|
≥95% |
38363-41-6 |
50mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
(+)-Penbutolol
|
P651513-10mg
|
≥95% |
38363-41-6 |
10mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
(+)-Penbutolol
|
P651513-100mg
|
≥95% |
38363-41-6 |
100mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
piCRAC-1
|
P651486-5mg
|
≥98% |
2418049-54-2 |
5mg
|
¥ 2080.9
|
期货,请咨询 |
阿拉丁 |
piCRAC-1
|
P651486-50mg
|
≥98% |
2418049-54-2 |
50mg
|
¥ 10240.9
|
期货,请咨询 |
阿拉丁 |
piCRAC-1
|
P651486-25mg
|
≥98% |
2418049-54-2 |
25mg
|
¥ 6400.9
|
期货,请咨询 |
阿拉丁 |